The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Smoking Linked to Teenage ADHD Impulsivity, Inattention
The likelihood of smoking addiction is associated with traits also closely associated with worsened ADHD.
ADHD Coaching an Emerging Tool for Patients
An ADHD coach can work on more goal-based plans for individuals with ADHD.
Postnatal Smoke Exposure Likely Significant Risk Factor for ADHD in Children
A study finds that secondhand smoking may have a greater negative impact on children than prenatal smoke exposure.
Study Finds Parental Concerns of Autism Do Not Align with Reported Behaviors
There is a high association between parents' concerns of autism spectrum disorder in their children and identified symptoms of ADHD.
Deirdre McCarthy: The Long Pursuit of a Fragile X Syndrome Treatment
There is currently no approved treatment for fragile X syndrome.
Novel SMS Strategy May Help Increase Stimulant Adherence in Adults with ADHD
Current estimates indicate that non-adherence to stimulants is as high as 87%.
Sleep Regularity, Timing Could Influence ADHD Symptoms in Teens
New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.
ADHD Impulsivity Linked to Greater COVID-19 Distress
Though the correlation is concerning for at-risk groups, experts believe it could inform individualized psychiatric care during crises.
ADHD Assessments Conducted Via Telehealth May Not Disadvantage Children
The APSARD study finds that most neuropsychological assessment scores did not differ significantly between both in-person and virtual visit modalities.
Andrew J. Cutler, MD: The Value of Delayed Release ADHD Treatments
Methylphenidate has shown promising boosting morning function in pediatric patients with ADHD.
Omega-3 Fatty Acids, Inositol Could Benefit Pediatric Bipolar Disorder
Both monotherapy and combination of the unique regimen was shown to improve manic and depressive status at 12 weeks.
Comorbidities Related to Pediatric ADHD May Be Characterized Using CBCL
The Child Behavior Checklist may provide invaluable information to clinicians regarding the type and severity of comorbid psychopathologies.
Andrew J. Cutler, MD: Delayed and Extended Release Methylphenidate Shows Promise
The treatment improves morning function for adolescent ADHD patients.
David W. Goodman, MD: Silver Linings in ADHD
Dr. David Goodman predicts some patients may improve their organizational skills during the pandemic.
David W. Goodman, MD: Adult ADHD Challenges During COVID-19
Adults with ADHD may face a number of challenges during the ongoing pandemic.
David W. Goodman, MD: APSARD 2021 Bringing Together International ADHD Research
The virtual conference will feature researchers from the US, Germany, Japan, and more.
Novel Educational Programs Can Benefit and Engage Sickle Cell Patients
Children with sickle cell disease have the opportunity to learn about STEM concepts in the context of their own condition.
The Absolute Benefit of Daratumumab for Relapsed Refractory Multiple Myeloma
A continued conversation on the intricate, patient-centric benefits of care with the subcutaneous agent.
Elliott Vichinsky, MD: Voxelotor and New HOPE Data for Sickle Cell
The UCSF hematologist discusses the growing portfolio for the sickle cell therapy after ASH 2020.
Sickle Cell Neurocognitive Screening Measures May Have Inherent Educational Bias
New ASH data demonstrates that RUDAS and MoCA scores are associated with highest level of education.
Luspatercept for Beta-Thalassemia May Reduce Transfusion Burden, Maintain QoL
Luspatercept added to best supportive care reduced transfusion burden while TranQol and SF-36 HRQoL scores were maintained through Week 48.
New Lintuzumab Combination Therapy for AML Safe, Potentially Effective
A Phase I study reports on the safety and potential efficacy of lintuzumab Ac225 plus CLAG-M for relapsed/refractory acute myeloid leukemia.
Largest Hemophilia B Gene Therapy Study to Date Hits Early Benefit, Safety Marks
The historic phase 3 HOPE-B trial shows all but 1 treated patient discontinued prophylaxis after a single dose of etranacogene deaparvovec.
New Gene Therapy Product ARU-1801 Shows Durable, Safe Sickle Cell Effect
The second process of ARU-1801 in a new patient resulted in up to 4 times greater engraftment of transduced hematopoietic stem cells and progenitors at 6 months.
Daratumumab Plus Pomalidomide Significantly Benefits Relapsed/Refractory Multiple Myeloma
An interview with a Janssen expert on the growing portfolio and newest data for daratumumab.
Cerebral Arteriopathy Risk More Common in Sickle Cell Anemic Children
The sickle cell disease subtype is associated with increased risk among patients as young as 2 years old.
New PKR Activator for Sickle Cell Shows Promising Safety, Efficacy Results
In data presented at ASH 2020, FT-4204 shows early potential in being safe, efficacious treatment for sickle cell disease.
Mitapivat Demonstrates Safety, Tolerability Among Sickle Cell Disease Patients
The ongoing phase I study also demonstrates that the drug is associated with an increase in Hb from baseline with a concomitant decrease in hemolytic markers.
Early Initiation of Rivipansel for VOC in Sickle Cell Disease
Early initiation reduces hospital stays and length of IV opioid use.
Exercise-Induced Vital Sign Changes May Predict Sickle Cell Prognosis
Analyses of vital sign changes from the 6-minute walk test may be indicative of cardiopulmonary function and potential survival among patients with sickle cell disease.